Product Description
Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. It inhibits the growth of struvite crystals produced by P. mirabilis in artificial urine and the growth of H. pylori in vitro (MICs = 200 and 400 mg/L for various isolates of H. pylori). Chronic AHA administration in dogs dose-dependently reduces urine urease activity, pH, and crystalluria and inhibits growth of bladder stones
Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. It inhibits the growth of struvite crystals produced by P. mirabilis in artificial urine and the growth of H. pylori in vitro (MICs = 200 and 400 mg/L for various isolates of H. pylori). Chronic AHA administration in dogs dose-dependently reduces urine urease activity, pH, and crystalluria and inhibits growth of bladder stones
Biovision | B3286 | Acetohydroxamic acid DataSheet
Alternate Name/Synonyms: NSC 408425 NSC 176136 NSC 5073 AHA
Appearance: White to yellow solid
Formulation:
CAS Number: 546-88-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂H₅NO₂
Molecular Weight: 75.07
Cell-Permeable?: True
Purity: ≥98%
Solubilities: >15 mg/ml DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An irreversible urease inhibitor
MDL Number: MFCD00009994
PubChem CID: 1990
SMILES: ONC(C)=O
InChi: InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)
InChi Key: RRUDCFGSUDOHDG-UHFFFAOYSA-N